(Q38097400)

28 August 2017

title

The type 1 insulin-like growth factor receptor signalling system and targeted tyrosine kinase inhibition in cancer (English)

1 reference

28 August 2017

Minoru Haisa

1

1 reference

28 August 2017

publication date

5 March 2013

1 reference

Journal of International Medical Research

28 August 2017

published in

1 reference

28 August 2017

volume

41

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

253-264

1 reference

Growth factors in development, transformation, and tumorigenesis

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Targeting the insulin-like growth factor network in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Targeting the insulin growth factor receptor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

The Insulin-like Growth Factor Signaling Pathway as a Target for Treatment of Colorectal Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Receptor tyrosine kinases and targeted cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Molecular and cellular aspects of the insulin-like growth factor I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Structure and function of the type 1 insulin-like growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Mevalonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface. Evidence for a new link between 3-hydroxy-3-methylglutaryl-coenzyme a reductase and cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Structure and autoregulation of the insulin-like growth factor 1 receptor kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

The genetics of human longevity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Structure of apo, unactivated insulin-like growth factor-1 receptor kinase at 1.5 Å resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Immunological relationships between receptors for insulin and insulin-like growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Control of cell survival by IGF signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Differential roles of insulin-like growth factor receptor- and insulin receptor-mediated signaling in the phenotypes of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Structural basis for the lower affinity of the insulin-like growth factors for the insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Insulin-like growth factors and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Chromaffin cells express two types of insulin-like growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Cellular actions of the insulin-like growth factor binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

PTEN-induction in U251 glioma cells decreases the expression of insulin-like growth factor binding protein-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

IGF binding proteins (IGFBPs) and regulation of breast cancer biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

SOS phosphorylation and disassociation of the Grb2-SOS complex by the ERK and JNK signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Ets ternary complex transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Activating p38 MAPK: new tricks for an old kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Structural Basis of Human p70 Ribosomal S6 Kinase-1 Regulation by Activation Loop Phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Cardiac insulin-like growth factor-1 and cyclins gene expression in canine models of ischemic or overpacing cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

The role of the IGF system in cancer growth and metastasis: overview and recent insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

The insulin-like growth factor system and its pleiotropic functions in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Sex steroids upregulate the IGF-1R in prostate cancer cells through a nongenotropic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Expression of IGF-1R in colorectal polyps and its role in colorectal carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of th

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Prognostic associations of insulin-like growth factor-1 receptor in primary uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Gene expression profiling in multiple myeloma--reporting of entities, risk, and targets in clinical routine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Efficacy of anti-insulin-like growth factor I receptor monoclonal antibody cixutumumab in mesothelioma is highly correlated with insulin growth factor-I receptor sites/cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Enhanced efficacy of IGF1R inhibition in pediatric glioblastoma by combinatorial targeting of PDGFRα/β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

IGF-I receptor signalling in transformation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

The IGF‐1 receptor in cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Increased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Human monoclonal antibodies targeting nonoverlapping epitopes on insulin-like growth factor II as a novel type of candidate cancer therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: lessons from the first clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Role of tyrosine kinase inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Insulin, insulin-like growth factors and neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

The insulin-like growth factor receptor 1 is a promising target for novel treatment approaches in neuroendocrine gastrointestinal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Insulin-like growth factor-1 receptor and ligand targeting in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Effects of insulin-like growth factor-1 receptor inhibition in mesothelioma. Thoracic Surgery Directors Association Resident Research Award

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Tyrosine kinase of insulin-like growth factor receptor as target for novel treatment and prevention strategies of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Preclinical in vivo study of new insulin-like growth factor-I receptor--specific inhibitor in Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Insulin-like growth factor-I receptor blockade by a specific tyrosine kinase inhibitor for human gastrointestinal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513476585

21 January 2018

Identifiers

DOI

10.1177/0300060513476585

1 reference

28 August 2017

1 reference